A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Clinical trial NCT02827513 · TERMINATED

Trial details

NCT number

NCT02827513

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2015-12-01

Primary completion

2016-01-01

Enrollment

16

View on ClinicalTrials.gov